2026– date –
-
Oral GLP-1 Receptor Agonist Elecoglipron Achieves Up to 11.8% Weight Loss and 7% Blood Sugar Reduction in Phase 2b Trials
Medical News Today (citing The Lancet) International Overview Once-daily oral GLP-1 receptor agonist elecoglipron demonstrated significant efficacy in its Phase 2b SOLSTICE clinical trial. Obese and overweight adults achieved up to an 11... -
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for SMA Patients with Suboptimal Gene Therapy Response
Cure SMA USA Overview Biogen's investigational spinal muscular atrophy (SMA) therapy, salanersen, has received Breakthrough Therapy Designation from the FDA. This designation is based on promising Phase 1b data in pediatric SMA patients ... -
Biologically-Driven Generative Chemistry: Advanced Deep Generative Models for De Novo Drug Design
ChemRxiv International Overview A new preprint study reviews biologically-driven generative chemistry, emphasizing deep generative models for novel molecular design. These models now integrate diverse biological data, including bioassays... -
Isomorphic Labs Secures $2.1B Series B Funding to Scale AI Drug Discovery Platform ‘IsoDDE’
IntuitionLabs UK Overview Isomorphic Labs, a Google DeepMind spin-off, has successfully raised $2.1 billion in Series B funding to globally expand its AI-driven drug discovery platform, 'IsoDDE,' and advance multiple drug programs. Built... -
Halia Therapeutics’ Ofirnoflast (HT-6184) Receives FDA Fast Track Designation for Lower-Risk MDS
BioUtah USA Overview Halia Therapeutics' Ofirnoflast (HT-6184), an oral NEK7 allosteric modulator for lower-risk myelodysplastic syndromes (LR-MDS), has been granted FDA Fast Track designation. This decision follows promising Phase 2 dat... -
AI Propels Drug Discovery with Breakthroughs in Protein Structure Prediction and Generative Molecular Design
AI Medicine Today USA Overview Artificial intelligence is dramatically accelerating drug discovery across multiple stages, from target identification to clinical trial optimization. DeepMind's AlphaFold has revolutionized protein structu... -
US DOE Awards Significant Grant to University Consortium for Advanced Solid-State Battery Research, Targeting Next-Gen Materials and Cell Structures
EurekAlert! USA Overview The U.S. Department of Energy (DOE) has awarded a substantial grant to a university consortium to advance fundamental science and engineering challenges in all-solid-state batteries. This new research program aim... -
Honda Reportedly Explores Joint Venture for Solid-State Battery Manufacturing in North America, Localizing EV Supply Chain
Automotive News Japan Overview Honda is reportedly exploring the establishment of a joint venture for solid-state battery manufacturing in North America. This strategic move aims to localize its electric vehicle (EV) battery supply chain... -
Blue Solutions Reports Steady Progress in Solid-State Battery Rollout for Electric Buses, Demonstrating Robust Performance and Safety in Commercial Fleets
Transport Topics France Overview Blue Solutions, a subsidiary of Bolloré Group, has reported consistent progress in the deployment of its all-solid-state battery technology for electric buses. The company highlighted the robust performan... -
Targray Inks Supply Agreement for High-Purity Lithium Metal Foil to Accelerate Solid-State Battery R&D and Prototyping
PR Newswire Canada Overview Targray has announced a new supply agreement for high-purity lithium metal foil, specifically dedicated to solid-state battery research and development (R&D) efforts. This contract ensures the provision of...
